- uniQure stock falls 10.38 percent as cash reaches USD 810.3 million - AD HOC NEWS
- Multi-million dollar grants aim to advance hairy cell leukemia research - News-Medical
- Protein modification network plays vital role in cancer development - News-Medical
- Pharmacy Cybersecurity Risks From Phishing and Vishing
- Specialty Pharmacy DEA Inspections - Be Prepared
- Huntington's Disease Market is Projected to Grow at 14% CAGR by 2036 Owing to ... - Barchart.com
- Huntington's Disease Market is Projected to Grow at 14% CAGR - openPR.com
- Kidney rhythm mismatch linked to dangerous nighttime high blood pressure - News-Medical
- Mayo Clinic strategy restores CAR T targets on aggressive thyroid tumours
- Latus Bio appoints Donald Hayden as chairman and Michael MacLean as independent director
- Vaccinex stock trades flat at USD 1.00 after a thin session
- Positive FDA Alignment Boosts ATyr Pharma's Rare Lung Disease - Yahoo Finance Singapore
- Gene Therapy in CNS Disorder Therapeutics Market Size in the 7MM - openPR.com
- What I wish healthcare workers knew about racial bias and rare disease
- SKY-0515 Shows Sustained Benefit at 15 Months in Huntington Disease | NeurologyLive
